Active Ingredient: REPAGLINIDE
Proprietary Name: REPAGLINIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 1MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A077571
Product Number: 002
Approval Date: Jul 11, 2013
Applicant Holder Full Name: SUN PHARMACEUTICAL INDUSTRIES INC
Marketing Status:
Prescription
Patent and Exclusivity Information